Circulating endothelial microparticles as a marker of cerebrovascular disease

Annals of Neurology

Volumn 66, Issue 2, 2009, Pages 191-199

  Jung, Keun Hwa ^a,b   Chu, Kon ^a,b   Lee, Soon Tae ^a,b   Park, Hee Kwon ^a,b   Bahn, Jae Jun ^a   Kim, Dong Hyun ^a   Kim, Jin Hee ^a   Kim, Manho ^a,b   Sang, Kun Lee ^a,b   Roh, Jae Kyu ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD31 ANTIGEN; CD62E ANTIBODY; GLYCOPROTEIN IB ALPHA; LIPOCORTIN 5; UNCLASSIFIED DRUG;

ACUTE DISEASE; AGED; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; BRAIN INFARCTION SIZE; CARDIOVASCULAR RISK; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; EXTRACRANIAL ARTERIAL STENOSIS; FEMALE; FLOW CYTOMETRY; FRACTIONATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

AGED; ANNEXIN A5; ANTIGENS, CD31; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; CEREBROVASCULAR DISORDERS; CONSTRICTION, PATHOLOGIC; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RISK FACTORS; STROKE;

EID: 70149092328     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21681     Document Type: Article

References (36)

1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004;34:392-401.
2. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003;1:1655-1662.
3. Leeuwenberg JF, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992;77:543-549.
4. Kagawa H, Komiyama Y, Nakamura S, et al. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. Thromb Res 1998;91:297-304. (Pubitemid 28454727)
5. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102.
6. Jimenez JJ, Jy W, Mauro LM, et al. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001;112:81-90. (Pubitemid 32151154)
7. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001;56:1319-1324. (Pubitemid 32455291)
8. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-180. (Pubitemid 36712905)
9. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-1471. (Pubitemid 40615620)
10. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-970. (Pubitemid 36688245)
11. Ferreira AC, Peter AA, Mendez AJ, et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004;110:3599-3603.
12. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000;101:841-843. (Pubitemid 30117876)
13. Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006;98:70-74. (Pubitemid 43902682)
14. Werner N, Wassmann S, Ahlers P, et al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006;26:112-116. (Pubitemid 44412832)
15. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-2652. (Pubitemid 33108128)
16. Lindsberg PJ, Carpén O, Paetau A, et al. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996;94:939-945. (Pubitemid 26292844)
17. Gürsoy-Ozdemir Y, Can A, Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004;35:1449-1453. (Pubitemid 38697474)
18. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001;33:1673-1690. (Pubitemid 32844225)
19. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
20. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135.
21. Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-1302. (Pubitemid 43756708)
22. Williams JB, Jauch EC, Lindsell CJ, Campos B. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Acad Emerg Med 2007;14:685-690. (Pubitemid 47058288)
23. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
24. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847. (Pubitemid 28213628)
25. Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-646. (Pubitemid 30210425)
26. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445-453.
27. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434. (Pubitemid 38129746)
28. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004;2:1842-1851.
29. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003;22:37-40. (Pubitemid 36131972)
30. Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke 1999;30:1319-1325.
31. Bae HJ, Yoon BW, Kang DW, et al. Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006;21:112-119.
32. Kappelle LJ, Eliasziw M, Fox AJ, et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. Stroke 1999;30:282-286. (Pubitemid 29071790)
33. Bang OY, Lee PH, Yoon SR, et al. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005;76:1128-1134.
34. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
35. Guijarro C. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease (letter). Circulation 2001;104:E127.
36. Takahashi W, Ohnuki T, Ide M, et al. Stroke risk of asymptomatic intra- and extracranial large-artery disease in apparently healthy adults. Cerebrovasc Dis 2006;22:263-270. (Pubitemid 44338089)